ID   MCF-7 M13
AC   CVCL_UU87
SY   M13
DR   cancercelllines; CVCL_UU87
DR   Wikidata; Q95986057
RX   PubMed=1727631;
CC   Population: Caucasian.
CC   Sequence variation: Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 4172; GATA3; Simple; p.Asp336Glyfs*17 (c.1006dupG); Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 8975; PIK3CA; Simple; p.Glu545Lys (c.1633G>A); ClinVar=VCV000013655; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; 2640; CYP3A7.
CC   Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C4194; Invasive breast carcinoma of no special type
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0031 ! MCF-7
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 25-02-19; Last updated: 10-09-24; Version: 9
//
RX   PubMed=1727631; DOI=10.1016/0003-9861(92)90061-Z;
RA   Kitamura R., Sato K., Sawada M., Itoh S., Kitada M., Komori M.,
RA   Kamataki T.;
RT   "Stable expression of cytochrome P450IIIA7 cDNA in human breast cancer
RT   cell line MCF-7 and its application to cytotoxicity testing.";
RL   Arch. Biochem. Biophys. 292:136-140(1992).
//